Hospital Pharmacy welcomes contributions to this column. Articles originally published in pharmacy department newsletters are reprinted here. Material is selected because of its educational value to pharmacists or because it demonstrates the type of information of interest to newsletter readers. If you wish to have your newsletter material considered for publication in this column, mail a copy to Facts and Comparison, Attn: Journal Editor, Hospital Pharmacy, 111 West Port Plaza, Suite 300, St. Louis, MO 63146-3098.
Get full access to this article
View all access options for this article.
References
1.
WelageL.S., BerardiR.R.Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. J Am Pharm Assoc.2000; 40: 52–62.
2.
BustamanteM., StollmanN.The efficacy of proton-pump inhibitors in acute ulcer bleeding. J Clin Gastroenterol.2000; 30: 7–13.
LabenzJ., PeitzU., LeusingC.Efficacy of primed infusions with high dose rani-tidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: A prospective randomized controlled study. Gut.1997; 40: 36–41.
5.
LinH.J., LoW.C., LeeF.Y.A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med.1998; 158: 54–8.
6.
SaltzmanJ.R., ZawackiJ.Therapy for bleeding peptic ulcers. N Engl J Med.1997; 336: 1091–3.
7.
Schaffalitzky de MuchadellO.B., HavelundT., HarlingH.Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Scand J Gastroenterol.1997; 32: 320–7.
8.
HasselgrenG., LindT., LundellL.Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Scand J Gastroenterol.1997; 32: 328–33.
9.
HartmannM.EhrlichA, FuderH, Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole. Aliment Pharmacol Ther.1998; 12: 1027–32.
10.
MetzD.C., PrathaV., MartinP.Oral and intravenous dosage forms of pantoprazole are equivalent in their ability to suppress gastric acid secretion in patients with gastroe-sophageal reflux disease. Am J Gastroenterol.2000; 95: 626–33.
11.
BrunnerG., LunaP., HartmannM., WurstW.Optimizing the intragastric pH as a supportive therapy in upper GI bleeding. Yale J Biol Med.1996; 69: 225–31.
12.
KhurooM.S., YattooG.N., JavidG.A comparison of omeprazole and placebo for bleeding peptic ulcer. N Engl J Med.1997; 336: 1054–8.
13.
CookD., HeylandD., GriffithL.Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Crit Care Med.1999; 27: 2812–17.
14.
LamN.P., LeP.D.T., CrawfordS.Y.National survey of stress ulcer prophylaxis. Crit Care Med.1999; 27: 98–103.
15.
LaskyM.R., MetzlerM.H., PhillipsJ.O.A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma.1998; 44: 527–33.
16.
LewE.A., PisegnaJ.R., StarrJ.A.Intravenous pantoprazole rapidly controls gastric acid hypersecretion in patients with Zollinger-Ellison Syndrome. Gastroenterol.2000; 118: 696–704.
SchusterD.P.Wringing blood from a turnip. Crit Care Med.1999; 27: 2846–7.
19.
SharmaV.K., VasudevaR., HowdenC.W.Simplified lansoprazole suspension-a liquid formulation of lansoprazole-effectively suppresses intragastric acidity when administered through a gastrostomy. Am J Gastroenterol.1999; 94: 1813–17.
20.
PhillipsJ.O., MetzlerM.H., PalmieriT.L.A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med.1996; 24: 1793–1800.
